Literature DB >> 31629421

The AR-DNA repair axis: insights into prostate cancer aggressiveness.

Karen E Knudsen1.   

Abstract

Despite significant advances in understanding the biology of advanced prostate cancer and approval of novel therapeutic agents, there is no durable cure for metastatic disease. Recent findings unmasked the importance of androgen receptor (AR) signaling in regulation of DNA repair, and alterations of the AR-DNA repair factor axis were shown to promote aggressive phenotypes including metastasis. These and related findings underscore the importance of determining impact AR-DNA repair factor alterations on prostate cancer progression.

Entities:  

Year:  2019        PMID: 31629421

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  2 in total

1.  Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration-resistant prostate cancer.

Authors:  Mingqiu Hu; Jing Ning; Likai Mao; Yuanyuan Yu; Yu Wu
Journal:  Oncol Lett       Date:  2020-11-19       Impact factor: 2.967

Review 2.  BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside.

Authors:  Stergios Boussios; Elie Rassy; Michele Moschetta; Aruni Ghose; Sola Adeleke; Elisabet Sanchez; Matin Sheriff; Cyrus Chargari; Nicholas Pavlidis
Journal:  Cancers (Basel)       Date:  2022-08-11       Impact factor: 6.575

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.